| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |